NCT02278263View on ClinicalTrials.gov

Tranexamic Acid in Knee Joint Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

March 31, 2016

Conditions
Osteoarthritis
Interventions
DRUG

Tranexamic Acid

Given intravenously or topically

DRUG

Normal saline (0.9% NaCl)

Administered in all 3 groups

Trial Locations (5)

Unknown

Auckland Hospital, Auckland

Manukau Surgery Centre, Auckland

North Shore Hospital, Auckland

Nelson Hospital, Nelson

Tauranga Hospital, Tauranga

All Listed Sponsors
lead

Andrew G Hill, MBChB, MD (Thesis), EdD, FACS, FRACS

OTHER

NCT02278263 - Tranexamic Acid in Knee Joint Surgery | Biotech Hunter | Biotech Hunter